Loading

Panel: Emerging tech in CGT – What's next?

03 Sep 2025
Theatre 1
R&D, clinical innovation & translation
  • Cutting edge developments in CRISPR, gene editing and cell engineering
  • The next wave of in vivo and ex vivo gene therapies
  • What breakthroughs are expected to reshape the industry?
Chairperson
Miguel Forte, Chief Executive Officer & President, ISCT - Kiji Therapeutics
Speakers
David Sourdive, Co-founder, Executive Vice President CMC & Manufacturing - Cellectis
Oliver Dovey, Senior Director Functional Genomics - bit.bio
Stefanos Theoharis, Chief Executive Officer - OneChain Therapeutics